ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $150,069,885 | +92.0% | 4,794,565 | +72.9% | 0.18% | +81.6% |
| Q1 2023 | $78,150,883 | +408788.6% | 2,772,291 | +279.0% | 0.10% | +250.0% |
| Q4 2022 | $19,113 | -99.8% | 731,472 | +34.7% | 0.03% | +55.6% |
| Q3 2022 | $12,123,000 | -16.0% | 542,914 | +12.1% | 0.02% | -10.0% |
| Q2 2022 | $14,434,000 | +17.8% | 484,515 | +4.0% | 0.02% | +42.9% |
| Q1 2022 | $12,255,000 | +11.5% | 465,808 | -1.4% | 0.01% | +27.3% |
| Q4 2021 | $10,990,000 | -26.8% | 472,471 | -2.9% | 0.01% | -35.3% |
| Q3 2021 | $15,011,000 | – | 486,738 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |